Premium
Optos‐guided pattern scan laser (Pascal)‐targeted retinal photocoagulation in proliferative diabetic retinopathy
Author(s) -
Muqit Mahiul M. K.,
Marcellino George R.,
Henson David B.,
Young Lorna B.,
Patton Niall,
Charles Stephen J.,
Turner George S.,
Stanga Paulo E.
Publication year - 2013
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2011.02307.x
Subject(s) - medicine , diabetic retinopathy , ophthalmology , retinal , fluorescein angiography , pascal (unit) , visual acuity , retinopathy , perfusion , diabetes mellitus , endocrinology , physics , quantum mechanics
. Purpose: To investigate the clinical effects and safety of targeted pattern scan laser (Pascal) retinal photocoagulation (TRP) in proliferative diabetic retinopathy (PDR). Methods: Prospective and non‐randomized study of 28 eyes with treatment‐naive proliferative diabetic retinopathy (PDR). Single‐session 20‐ms‐Pascal TRP strategy applied 1500 burns to zones of retinal capillary non‐perfusion and intermediate retinal ischaemia guided by wide‐field fluorescein angiography (Optos). Main outcome measures at 12 and 24 weeks included; PDR grade (assessed by two masked retina specialists); central retinal thickness (CRT); mean deviation (MD) using 24‐2 Swedish interactive threshold algorithm (SITA)‐standard visual fields (VF); and ETDRS visual acuity (VA). Results: Following primary TRP, there was PDR regression in 76% of patients at 12 weeks (κ = 0.70; p < 0.001). No laser re‐treatment was required at 4 weeks, and 10 eyes underwent repeat TRP at 12 weeks. Wide‐field Optos angiography at 24 weeks showed complete disease regression in 37% and partial regression in 33%. Additional panretinal laser photocoagulation (PRP) was planned for active PDR in 30%. There were significant reductions in CRT over time (10.4 μm at 12‐weeks, p = 0.007; 12.1 μm at 24‐weeks, p = 0.0003). The MD on VFs improved after 12 weeks (+1.25 dB; p = 0.015) and 24 weeks (+1.26 dB, p = 0.01). The VA increased by +3 letters at 24 weeks (95% CI, 1.74–5.01; p < 0.0001). Conclusions: This pilot study reports that Optos‐guided Pascal 20‐ms TRP using 1500 burns for treatment‐naive PDR is a promising procedure with favourable safety profile.